Header

UZH-Logo

Maintenance Infos

Testing the cancer stem cell hypothesis in melanoma: The clinics will tell


Shakhova, Olga; Sommer, Lukas (2013). Testing the cancer stem cell hypothesis in melanoma: The clinics will tell. Cancer Letters, 338(1):74-81.

Abstract

Whether tumorigenic cancer stem cells (CSCs) exist in melanoma has been the focus of much controversy in recent years. A number of studies have pointed to the existence of melanoma cell sub-populations that act as CSCs and can be distinguished from other tumor cells based on specific surface marker expression or specific properties such as the capacity for extensive self-renewal. Other studies failed to identify melanoma stem cells and proposed that the potential to initiate tumors is a wide spread feature in melanoma inherent to most if not all cells of the tumor mass. As with normal stem cells, the term CSC is based on an operational definition, indicating not just a tumor-initiating cell, but also a cell with the capacity to sustain long-term tumor propagation. Therefore, the experimental set-up chosen to identify putative CSCs in melanoma is crucial: Both the method of tumor cell preparation and the procedure used to assess CSC properties in vivo influence the experimental outcome and hence its interpretation. In this review, we summarize our current knowledge on CSCs and the role of stem cell properties in melanoma and discuss recent findings with respect to their clinical relevance.

Abstract

Whether tumorigenic cancer stem cells (CSCs) exist in melanoma has been the focus of much controversy in recent years. A number of studies have pointed to the existence of melanoma cell sub-populations that act as CSCs and can be distinguished from other tumor cells based on specific surface marker expression or specific properties such as the capacity for extensive self-renewal. Other studies failed to identify melanoma stem cells and proposed that the potential to initiate tumors is a wide spread feature in melanoma inherent to most if not all cells of the tumor mass. As with normal stem cells, the term CSC is based on an operational definition, indicating not just a tumor-initiating cell, but also a cell with the capacity to sustain long-term tumor propagation. Therefore, the experimental set-up chosen to identify putative CSCs in melanoma is crucial: Both the method of tumor cell preparation and the procedure used to assess CSC properties in vivo influence the experimental outcome and hence its interpretation. In this review, we summarize our current knowledge on CSCs and the role of stem cell properties in melanoma and discuss recent findings with respect to their clinical relevance.

Statistics

Citations

Dimensions.ai Metrics
29 citations in Web of Science®
34 citations in Scopus®
33 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

17 downloads since deposited on 01 Mar 2013
8 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Institute of Anatomy
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2013
Deposited On:01 Mar 2013 12:23
Last Modified:16 Feb 2018 17:37
Publisher:Elsevier
ISSN:0304-3835
OA Status:Green
Publisher DOI:https://doi.org/10.1016/j.canlet.2012.10.009
PubMed ID:23073475

Download

Download PDF  'Testing the cancer stem cell hypothesis in melanoma: The clinics will tell'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 524kB